Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
BioNTech SE - American Depositary Shares
(NQ:
BNTX
)
108.26
+0.75 (+0.70%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BioNTech SE - American Depositary Shares
< Previous
1
2
3
4
5
6
7
8
9
...
68
69
Next >
Ex-Pfizer Exec Pulled Into House Probe Over Alleged COVID Vaccine Delay Through 2020 Election
June 30, 2025
The committee cited remarks allegedly made by Philip Dormitzer at GSK, claiming that Pfizer’s top R&D leaders delayed clinical trial progress to avoid releasing results before the 2020 election.
Via
Stocktwits
Topics
Government
Law Enforcement
Expert Outlook: BioNTech Through The Eyes Of 11 Analysts
June 25, 2025
Via
Benzinga
5 Stocks To Ride The German Market Rally
June 16, 2025
Via
Benzinga
Accenture To Rally More Than 13%? Here Are 10 Top Analyst Forecasts For Monday
June 16, 2025
Via
Benzinga
12 Analysts Have This To Say About BioNTech
June 03, 2025
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CureVac N.V. (Nasdaq - CVAC), Know Labs, Inc. (NYSE American - KNW), Volato Group, Inc. (NYSE American - SOAR), Heliogen, Inc. (OTC - HLGN)
June 13, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
Market Monitor News June 13 (Oracle UP - Gamestop DOWN)
June 13, 2025
U.S. stocks edge higher as inflation cools, Oracle soars on AI growth, and markets brace for Israel-Iran conflict escalation.
Via
Chartmill
Topics
Artificial Intelligence
Economy
BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal
June 12, 2025
BioNTech agreed to buy CureVac for $1.25 billion, expanding its mRNA cancer research and boosting its oncology pipeline.
Via
Benzinga
BioNTech To Acquire CureVac In All-Stock Deal Valued At $1.25B: Retail Sees Breakthrough In Cancer Treatment
June 12, 2025
Under the terms of the deal, each CureVac share will be exchanged for approximately $5.46 in BioNTech American depositary shares.
Via
Stocktwits
BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer
June 12, 2025
From
BioNTech SE
Via
GlobeNewswire
Robert Kennedy Jr Axes Entire CDC Vaccine Panel To 'Restore Public Trust' — Pfizer, Moderna, Other Biotech Stocks Drop In After-Hours Trading
June 10, 2025
A sweeping overhaul of the CDC's top vaccine advisory panel is ripping through the medical world, while rattling pharma and biotech stocks.
Via
Benzinga
Global Billion Dollar Oncology Industry Experiencing Substantial Growth Driven by Increasing Cancer Incidences
June 11, 2025
EQNX::TICKER_START (NNASDAQ:ONCY),(TSX:ONC),(NYSE:NVS),(NASDAQ:BNTX),(NASDAQ:ARVN),(NYSE:PFE),(NYSE:BMY) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Vaccine Stocks Alert: Has RFK Jr.'s CDC Panel Shakeup Sent Retail Traders To The Sidelines?
June 10, 2025
Kennedy said the Department of Health and Human Services would retire all 17 current members of the ACIP, citing what he called a "crisis of public trust."
Via
Stocktwits
Topics
Government
Global Billion Dollar Oncology Industry Experiencing Substantial Growth Driven by Increasing Cancer Incidences
June 11, 2025
From
FN Media Group LLC
Via
GlobeNewswire
Vaccine Stocks Moderna, Pfizer Hit After A Surprise Blow From RFK Jr.
June 09, 2025
A CDC committee in charge of making vaccine recommendations was gutted Monday to make way for a new coalition.
Via
Investor's Business Daily
Topics
Government
Micron To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Thursday
June 05, 2025
Via
Benzinga
Why Credo Technology Group Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
June 03, 2025
Via
Benzinga
Market Monitor News June 03 (Cleveland-Cliffs, Blueprint Medicines UP - First Solar DOWN)
June 03, 2025
Wall Street Climbs Despite Trade Tensions: Steel Stocks Shine, Apple Impresses
Via
Chartmill
Why BioNTech Stock Soared Today
June 02, 2025
Bristol Myers Squibb just agreed to shower BioNTech with cash.
Via
The Motley Fool
Bristol Myers Inks $11 Billion Licensing Pact With BioNTech For Bispecific Cancer Drug
June 02, 2025
BioNTech and Bristol Myers Squibb will co-develop BNT327 for solid tumors in a $1.5 billion deal with potential milestones totaling up to $7.6 billion.
Via
Benzinga
Bristol Myers To Pay Up To $11.1B To BioNTech To Co-Develop, Commercialize Investigational Cancer Drug
June 02, 2025
BMS will pay BioNTech $1.5 billion in an upfront payment in the second quarter and $2 billion in non-contingent anniversary payments through 2028.
Via
Stocktwits
Topics
Government
Why Blueprint Medicines Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket
June 02, 2025
Via
Benzinga
BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and Co-Commercialize Next-generation Bispecific Antibody Candidate BNT327 Broadly for Multiple Solid Tumor Types
June 02, 2025
From
Bristol Myers Squibb
Via
Business Wire
BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and Co-Commercialize Next-generation Bispecific Antibody Candidate BNT327 Broadly for Multiple Solid Tumor Types
June 02, 2025
From
BioNTech SE
Via
GlobeNewswire
Robert F. Kennedy Jr. Says CDC Drops COVID Vaccine For 'Healthy' Pregnant Women, Children
May 27, 2025
RFK Jr. says the COVID-19 vaccine is no longer on the CDC's recommended schedule for healthy kids and pregnant women, though the official site still shows it listed.
Via
Benzinga
BioNTech to Present Progress Across Diversified Oncology Pipeline at the 2025 ASCO Annual Meeting
May 27, 2025
From
BioNTech SE
Via
GlobeNewswire
FDA Limits Annual COVID-19 Boosters To High-Risk Americans, Demands New Trials For Healthy Adults In Policy Shift Under RFK Jr.
May 21, 2025
The U.S. Food and Drug Administration has announced significant changes to COVID-19 vaccine requirements, limiting annual booster approvals to older and high-risk Americans while implementing stricter...
Via
Benzinga
What's Going On With Vaccine Stocks Today?
May 20, 2025
Shares of Vaccine stocks are moving higher on Tuesday after documents from the U.S. Food and Drug Administration revealed that its advisers will meet this week.
Via
Benzinga
The FDA Is Limiting Covid Shots. But Moderna, Vaccine Stocks Jumped.
May 20, 2025
The new framework limits future Covid shots to people age 65 and older and those six months and older with a risk factor for serious illness.
Via
Investor's Business Daily
Topics
Bankruptcy
Government
Novavax Scores Key FDA Win, Shares Jump 19% As Sanofi Unlocks Milestone Payment
May 19, 2025
Novavax's COVID-19 vaccine, Nuvaxovid™, receives limited FDA approval and triggers $175M milestone payment. Commercial distribution planned for fall.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
68
69
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.